Content related to Could a Key Protein Lead to New Therapies for Wilms Tumor?

Findings may lead to better diagnosis and treatment of childhood kidney cancer.

The ambitions of pediatric researchers are global in scale: Beyond patients at their own hospital, they look to shape national and international standards for pediatric care.

CHLA researchers uncover mechanisms driving adult membranous nephropathy, which could potentially lead to novel treatments for pediatric chronic kidney disease.

Dr. Sedrakyan is studying interventions to address the mechanisms behind Alport syndrome, a genetic condition that can lead to kidney disease.

Two federal grants are supporting efforts at Children’s Hospital Los Angeles to develop novel therapies for this aggressive childhood brain tumor.

A new study finds that blocking Artemis significantly reduces the proliferation of leukemia cells, without affecting normal cells.

After a move to the U.S. disrupted her career, Dr. Soloyan found a passion for research and regenerative medicine.

Poster session finalists were voted on by a scientific committee and presented key takeaways from their research during Science Day 2024.